InVasc Therapeutics Adds Two Leaders to Scientific Advisory Board
4/5/2012 11:23:49 AM
More...
|
InVasc Therapeutics Initiates Phase IIa Proof of Concept Study with INV-144 in Patients with Chronic Kidney Disease
6/24/2011 9:32:51 AM
More...
|
InVasc Therapeutics In-Licenses BioLink Patent Application for Alpha Lipoic Acid Salt for Use in Chronic Kidney Disease
5/3/2011 11:27:45 AM
More...
|
Frank Kelly, Jr. Appointed to InVasc Therapeutics Board of Directors
9/20/2010 9:44:54 AM
More...
|
InVasc Therapeutics Announces Financing of $3.15 Million and Board Changes
7/9/2010 7:10:14 AM
More...
|
InVasc Therapeutics Awarded Two Phase 1 SBIR Grants
5/20/2010 10:51:00 AM
More...
|
Georgia Governor Issues Commendation Recognizing InVasc Therapeutics Founder and Board Member, Dr. Bobby V. Khan
1/19/2010 10:21:55 AM
More...
|
InVasc Therapeutics to Present at Biotech Showcase 2010 and Announces Domain Name Change
1/12/2010 10:48:30 AM
More...
|
InVasc Therapeutics Announces Executive and Board Appointments
5/15/2009 10:37:08 AM
More...
|